📢 Latest Update: UGC Discontinues CARE Journal Listing: New Guidelines for Selecting Peer-Reviewed Journals View Now

[email protected] (+91)9218093693
International Journal of Cell Biology and Cellular Functions Cover

International Journal of Cell Biology and Cellular Functions

| Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access

About the Journal

International Journal of Cell Biology and Cellular Functions is a peer-reviewed hybrid open-access journal launched in 2023 that aims to stimulate the scientifically grounded exchange of ideas. It contains timely reviews and original research articles, with emphasis on cellular processes and cell biology, including all major fields of research.

View full focus & scope More

Journal Information

Title: International Journal of Cell Biology and Cellular Functions
Abbreviation: ijcbcf
Issues Per Year: 2 Issues
Publisher: STM Journals
DOI: 10.37591/IJCBCF
Starting Year: 2023
Subject: Cell Biology and Cellular Functions
Publication Format: Hybrid Open Access
Copyright Policy: CC BY-NC-ND
Type: Peer-reviewed Journal (Refereed Journal)

Address:

STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd. A-118, 1st Floor, Sector-63, Noida, U.P. India, Pin - 201301

Editorial Board

View Full Editorial Board

ijcbcf maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Biswajit Majumdar, Professor

CALCUTTA UNIVERSITY INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH [IPGMER], Kolkata, India.,

Email :

Latest Articles

Ahead of Print

Exploring Oroxylum indicum Phytochemicals as VEGFR-2 Inhibitors: A Molecular Docking Approach for Cancer Management

Cancer is still a major health problem around the world and is one of the top causes of death. A protein called VEGFR-2 (vascular endothelial growth factor receptor 2) is important because it helps blood vessels grow by supporting the survival, movement, and growth of certain cells

VEGFR-2 inhibition, Oroxylum indicum, phytochemicals, molecular docking, tumor angiogenesis, cancer therapeutics

Molecular Docking Studies of Nyctanthes arbor-tristis Phytochemicals for Targeting TNF Receptor in Arthritis

Rheumatoid Arthritis is an autoimmune disorder which results in inflammation. Tumor necrosis factor-alpha (TNF-α) is responsible for the progression of inflammatory arthritis by promoting immune cell activation and cytokine release.

Nyctanthes arbor-tristis, arthritis, tumor necrosis factor receptor, molecular docking, phytochemicals, computational screening, ADMET analysis

Molecular Docking Analysis of Phytocompounds from Ficus hispida Against Epidermal Growth Factor Receptor Kinase Domain

The Epidermal Growth Factor Receptor (EGFR) kinase domain plays a key role in cancer, as it promotes tumour growth and helps cancer cells survive, making it an important focus for developing treatments.

Ficus hispida, EGFR kinase domain, molecular docking, molecular dynamics, ADME analysis, drug discovery, phytocompounds, cancer

Molecular Docking Analysis of Berberis aristata Phytocompounds as Potential Growth Factor Receptor Blockers in Cancer Therapy

Middle-aged and older women are susceptible to breast cancer (BC), a potentially fatal condition. When breast cancer is diagnosed, the median age is 62.

Breast cancer (BA), Human epidermal growth factor receptors (HER-2), ADMET analysis, Molecular docking, Berberis aristata (BA)

Drug Repurposing of Anticancer Agents JP-8g and REDX05358 Against the Target Protein Plectin 1a in Epidemolysis Bullosa Simplex with Muscular Dystrophy (EBS-MD)

Epidermolysis Bullosa Simplex with Muscle Dystrophy is a genetic disease affecting the skin and muscles which can be seen at birth or start at adulthood due to the mutation in the protein Plectin 1a (PLEC gene) causing skin blisters and muscle weakness.

Epidermolysis Bullosa Simplex with Muscular Dystrophy (EBS-MD), plectin 1a acting binding domain, ligands, JP-8g, REDX05358, PyRx, molecular docking, BIOVIA, ADME

Exploring Oroxylum indicum Phytochemicals as VEGFR-2 Inhibitors: A Molecular Docking Approach for Cancer Management

Cancer is still a major health problem around the world and is one of the top causes of death. A protein called VEGFR-2 (vascular endothelial growth factor receptor 2) is important because it helps blood vessels grow by supporting the survival, movement, and growth of certain cells.

VEGFR-2, Oroxylum indicum, phytochemicals, tumor angiogenesis
Fancy Responsive Footer